- Cancer Research UK Molecular Pharmacology Unit, University of Dundee
- Department of Surgery and Molecular Oncology, University of Dundee
- Department of Oncology, University of Edinburgh
- Cancer Research UK Medical Oncology Unit
- School of Cancer Studies, University of Glasgow
- Section of Experimental Haematology & Haemopoietic Stem Cells, University of Glasgow
- Cancer Research UK Beatson Laboratories, Glasgow
- Beatson Oncology Centre, Glasgow
- Cancer Research UK Formulation Unit, University of Strathclyde
Cancer Research UK Molecular Pharmacology Unit, University of Dundee
The Biomedical Research Centre provides a focus for excellence in biomedical research. It houses more than 120 researchers in 13 teams, attracting significant funding from charities, government agencies and industry.
The aim of the research is to understand the role of genetic and environmental factors in the pathogenesis of human disease, with a particular emphasis on cancer. It looks at the function and regulation of genes which determine the sensitivity of cells to therapeutic drugs and environmental agents.
The work is also relevant to degenerative diseases, cardiovascular disease and HIV infection.
The unit was awarded the highest rating possible (5*) in the latest Research Assessment Exercise (RAE).
Department of Surgery and Molecular Oncology, University of Dundee
Approximately ninety staff work in this department of the medical school at Ninewells Hospital. The multi-disciplinarily research team includes biochemists, cell biologists, surgeons, physicists and engineers.
In addition, the prestigious Wellcome Trust Biocentre, a £14 million development, is central to the School of Life Sciences within the University. This provides state of the art facilities for over 400 international scientists.
The University has a history of successful collaboration with world-wide industry through licensing, collaborative research programmes and joint ventures and is currently working with 8 out of 10 top pharmaceutical companies.
Department of Oncology, University of Edinburgh
The department has a wide variety of multidisciplinary research activity. This includes new forms of cancer treatment through development of population screening for predisposing mutations in colorectal and breast cancer, through to laboratory based research on tumorigenesis and especially leukaemogenesis.
The Division of Oncology, located in the MRC Human Genetics Building MRC Human Genetics Unit is part of the School of Molecular and Clinical Medicine at the Western General Hospital and is made up of staff from Clinical Oncology, the , the Colon Cancer Genetics Unit, the Prostate Research Group and the University of Edinburgh-Leukaemia Research Fund, John Hughes Bennett Laboratory.
Cancer Research UK Medical Oncology Unit
Cancer Research UK's Edinburgh Medical Oncology Unit aims to improve the therapeutic index of cancer treatment.
The unit's main areas of research include colorectal, ovarian, breast cancer, prostate and malignant melanomas.
It is currently researching the development of more selective anti-cancer medicines, and studying psychosocial factors relevant to understanding how best to translate laboratory advances into more effective patient management.
It also performs phases I/III clinical trials with the Edinburgh Cancer Centre.
School of Cancer Studies, University of Glasgow
The School for Cancer Studies is organised through Glasgow University and co-ordinates cancer-related research, therapy and education within associated Research Institutes, Hospitals and University departments.
There are currently over 150 members of the School and they include nurses, clinicians, general practitioners, lecturers, undergraduates, graduate students and lay people with interests in cancer.
Department of Molecular Oncology, University of Glasgow
The University of glasgow's department of molecular oncology is a major Cancer Research UK Trials Office, and manages full range of cancer clinical trials. The department conducts 70-80 trials per year
Areas of expertise include:
- method development;
- validation;
- pharmacokinetic analysis;
- drug and gene delivery to solid tumors; and,
- novel drug sensitivity mechanisms.
Section of Experimental Haematology & Haemopoietic Stem Cells, University of Glasgow
The Section of Experimental Haematology & Haemopoietic Stem Cells is a research group within the Division of Cancer Services and Molecular Pathology at the University of Glasgow's Faculty of Medicine.
The group's research is focused on the cellular and molecular characterisation of quiescent leukaemic stem cells in chronic myeloid leukaemia (CML) patients. They are currently taking two compounds through clinical trials.
The research group will be relocating to the new Leukaemia Research Centre, directed by Prof. Tessa Holyoake, as part of the new West of Scotland Cancer Centre complex at Gartnavel Hospital.
Cancer Research UK Beatson Laboratories, Glasgow
The Cancer Research UK Beatson Laboratories work to enhance the understanding of neoplastic growth and behaviour, with a view to improving prevention, diagnosis and treatment of cancer.
These aims are pursued by integrating the basic and strategic research of the Beatson Institute for Cancer Research with the translational research of the University of Glasgow Departments of Medical and Radiation Oncology, to form Scotland's premier cancer research enterprise.
The new £15 million Cancer Research UK Beatson Institute at the University of Glasgow’s Garscube Estate in Bearsden is a jointly funded centre by the University of Glasgow and Cancer Research UK. It will transform Scotland's research environment and bring a number of distinct benefits for the country's cancer patients.
The new building, due to be completed by the end of 2006, will house 240 cancer researchers and provide world-class research facilities, accelerating the process of understanding the disease, identifying new therapies and bringing them to patients.
Beatson Oncology Centre, Glasgow
The Beatson Oncology Centre has recently won accreditations as an approved coordinating centre for national Cancer research Institute (NCRI) trials, one of only three granted in the UK this year.
The Beatson Oncology Centre will be relocated to the new West of Scotland Cancer Centre, which will bring together some of the finest cancer treatment and research facilities in Europe for the first time under one roof.
It will also house Glasgow’s haemato-oncology (blood cancers) and palliative care services. They willl move from their current homes the Western Infirmary,Glasgow Royal Infirmary and Gartnavel General and Stobhill hospitals . The £8 million West of Scotland Bone Marrow Transplant Service is also moving to the Centre. Work will begin shortly on a new £8 million state-of-the-art laboratory which will centralise haematology, blood bank and biochemistry services on the Gartnavel site.
Cancer Research UK Formulation Unit, University of Strathclyde
The Unit serves around 20 clinical centres in the UK and has links with the National Cancer Institute in America and the European Organisation for Research into the Treatment of Cancer in Holland.
The Unit is completely funded by the Cancer Research UK Scientific Committee.